Welcome to our dedicated page for Organto Foods news (Ticker: OGOFF), a resource for investors and traders seeking the latest updates and insights on Organto Foods stock.
Organto Foods Inc. (OTCQX: OGOFF) generates news that reflects both its role in organic and fairtrade food supply chains and its activities in global capital markets. The company describes itself as an integrated provider of branded, private label, and distributed organic, fairtrade, and non-GMO fruit and vegetable products, supplying certified organic and fairtrade produce to leading international retailers. Its news flow often combines operational updates with financing and strategic developments.
Readers of Organto’s news can expect detailed announcements on financial performance, including quarterly and year-to-date results prepared under International Financial Reporting Standards. These releases may discuss sales growth, gross profit, operating expenses, and non-IFRS measures such as adjusted gross profit and EBITDA, along with commentary on restructuring progress and business realignment.
Organto also issues news about its capital structure and funding. Recent disclosures include non-brokered private placements of units with accompanying warrants, early warrant exercise incentive programs subject to TSX Venture Exchange acceptance, and the prepayment of convertible notes to optimize debt and potential dilution. The company has highlighted new financial and foreign exchange facilities with a Netherlands-based bank to support its European foods operations and manage currency risk.
Operational and strategic updates form another key part of Organto’s news. The company has reported on its participation in major industry events such as the Fruit Attraction conference in Madrid, its integrated farm-to-shelf model, and a refreshed brand identity aligned with an integrated global ecosystem. It has also announced its upgrade to trading on the OTCQX Best Market in the United States, emphasizing enhanced disclosure, governance standards, and broader investor reach.
For investors and observers following OGOFF, the news stream offers insight into Organto’s organic and fairtrade product platform, its asset-efficient supply chain, and its ongoing efforts to strengthen its balance sheet and expand its presence in healthy foods markets.
Organto Foods (OTC:OGOFF) has announced a non-brokered private placement to raise C$7.0 million through the issuance of up to 14 million units at C$0.50 per unit. Each unit includes one common share and one-half warrant, with each full warrant exercisable at C$0.75 for 18 months.
The company may pay finder's fees of up to 7.5% cash commission. The proceeds will support the growth of Organto's organic and fairtrade fruit and vegetable products and technology platform, along with general working capital. The private placement is subject to TSX Venture Exchange approval and includes a four-month hold period plus a twelve-month contractual transfer restriction.
Organto Foods (OTC:OGOFF) has appointed Javier Reyes de la Campa as Co-Chair of the Board of Directors, joining Steve Bromley in this leadership role. Reyes de la Campa, a Harvard Business School alumnus with over 25 years of experience in investing and company building, previously served on Organto's Board from 2015 to 2020.
The company has also granted 125,000 stock options to employees at an exercise price of $0.54 per share with a five-year term, and 1,000,000 restricted stock units to directors with a three-year term. The appointment comes as Organto focuses on accelerating growth and expanding its organic food product offerings.
Organto Foods (OTC:OGOFF) has completed the issuance of 4,380,000 common shares to Jaluca Limited at a deemed price of $0.10 per share. The shares were issued as compensation for Jaluca's corporate finance advisory services in the company's debt restructuring and convertible debentures settlement.
Additionally, the company disclosed details about its 2024 bonus program, with total bonuses of $822,000 to be paid to officers and key personnel. The bonus structure includes 70% in equity ($575,400) and 30% in cash ($246,600), with the equity portion already achieved in 2025 but not yet paid.
Organto Foods (OTC:OGOFF) has successfully closed a C$1.0 million private placement with a strategic investor. The company issued 4,000,000 units at $0.25 per unit, with each unit comprising one common share and one-half warrant.
Each whole warrant allows the purchase of one additional common share at $0.35 until December 26, 2026. The proceeds will be used for general working capital. A finder's fee of $60,000 was paid in connection with the placement. The securities are subject to a hold period until October 27, 2025.
Organto Foods (OTC:OGOFF) held its annual general meeting with strong shareholder participation, as 65,975,601 common shares representing approximately 57.9% of eligible outstanding shares were voted. All matters received over 99% support.
Shareholders elected five directors: Steve Bromley, Peter Damouni, Peter Gianulis, Alejandro Maldonado and Joe Riz. The meeting also approved the appointment of Dale Matheson Carr-Hilton Labonte LLP as the company's independent auditor and approved the continuation of Share Option and Restricted Share Unit Plans.
Organto Foods (OGOFF) has secured approval from debentureholders to settle its $8.05 million convertible unsecured subordinated debentures through the issuance of 40.25 million common shares at $0.20 per share. The debentures, originally due November 30, 2026, with an 8% interest rate, received 68.89% approval from holders, exceeding the required 66.7% threshold.
The settlement shares will be subject to a 30-month staged release restriction, with 25% portions being released at 21, 24, 27, and 30 months following issuance. The completion of this debt-to-equity conversion remains subject to TSX Venture Exchange approval.
Organto Foods (OGOFF) reported its fiscal 2024 financial results, showing significant growth with sales reaching $20.7 million, a 48% increase from the previous year's $14.0 million. The company's fourth quarter demonstrated strong momentum with sales of $6.5 million, up 107% year-over-year.
The company achieved a gross profit of $1.8 million (8.5% margin) for the full year, and $0.6 million (9.1% margin) in Q4. Notable events include the sale of three operating subsidiaries in June 2024, resulting in a $2.6 million gain. The company reported a net loss of $2.0 million for 2024, significantly improved from the $13.4 million loss in 2023.
The restructuring efforts included streamlining the product portfolio, refocusing market strategies, and reducing costs through internal reorganization. The company completed a private placement and shares for debt settlements, with convertible debentures expected to convert to equity.